Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

September 5, 2023

VVT Medical’s ScleroSafe System Receives FDA Clearance

September 5, 2023—VVT Medical, a medical device company headquartered in Israel, announced this summer that its ScleroSafe platform received FDA 510(k) clearance for nonthermal, nontumescent treatment and management of varicosities in superficial veins. The clearance paves the way for commercialization of the device in the United States, noted the company.

VVT Medical’s ScleroSafe has previously received approval in multiple regions, including Europe, Australia, Southeast Asia, and South America.

According to the company, ScleroSafe’s inverse-action dual syringe injects a sclerosing substance into the vein through one syringe while simultaneously aspirating blood and substance residuals through the second syringe within a single motion and with a single-handed operation.

Advertisement

September 6, 2023

Delcath Receives Funding Triggered by FDA Approval of Hepzato Kit

left-arrow Created with Sketch. Previous Article

September 5, 2023

Ichor Vascular’s 14-F Peripheral Reperfusion System Cleared by FDA

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)